Places
Home
Graphs
Prefixes
Admin
Users
Settings
Plugins
Statistics
Repository
Load local file
Load from HTTP
Load from library
Remove triples
Clear repository
Query
YASGUI SPARQL Editor
Simple Form
SWISH Prolog shell
Help
Documentation
Tutorial
Roadmap
HTTP Services
Login
Distinct subjects for predicate
<http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>
sorted by frequency
Resource
Count
ziprasidone_maximum_concentration_continuous_value
6
aripiprazole_maximum_concentration_continuous_value
5
paroxetine_inhibits_cyp2d6
5
perphenazine_substrate_of_cyp2d6
5
14-hydroxyclarithromycin_maximum_concentration_continuous_value
4
atorvastatin_maximum_concentration_continuous_value
4
clarithromycin_maximum_concentration_continuous_value
4
clozapine_maximum_concentration_continuous_value
4
diltiazem_bioavailability_continuous_value
4
ketoconazole_inhibits_cyp3a4
4
ziprasidone_substrate_of_cyp3a4
4
O-desmethylvenlafaxine_maximum_concentration_continuous_value
3
alprazolam_primary_total_clearance_mechanism_Metabolic_Clearance
3
alprazolam_substrate_of_cyp3a4
3
atorvastatin_has_metabolite_ortho-hydroxy-atorvastatin
3
atorvastatin_has_metabolite_para-hydroxy-atorvastatin
3
atorvastatin_substrate_of_cyp3a4
3
bupropion_maximum_concentration_continuous_value
3
chlorpromazine_maximum_concentration_continuous_value
3
cimetidine_increases_auc_imipramine
3
cinacalcet_inhibits_cyp2d6
3
citalopram_does_not_inhibit_cyp3a4
3
clarithromycin_inhibition_constant_cyp3a4
3
clarithromycin_inhibits_cyp3a4
3
cyp2d6_controls_formation_of_O-desmethylvenlafaxine
3
cyp3a4_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine
3
diltiazem_inhibition_constant_cyp3a4
3
duloxetine_inhibits_cyp2d6
3
erythromycin_inhibition_constant_cyp3a4
3
fluconazole_increases_auc_midazolam
3
fluconazole_inhibits_cyp3a4
3
fluoxetine_inhibits_cyp2d6
3
fluvastatin_maximum_concentration_continuous_value
3
fluvoxamine_inhibits_cyp1a2
3
indinavir_inhibits_cyp3a4
3
metronidazole_maximum_concentration_continuous_value
3
mexiletine_inhibits_cyp1a2
3
nefazodone_increases_auc_alprazolam
3
nefazodone_inhibits_cyp3a4
3
paroxetine_increases_auc_desipramine
3
quetiapine_substrate_of_cyp3a4
3
ritonavir_inhibits_cyp3a4
3
sertraline_increases_auc_desipramine
3
sertraline_inhibits_cyp2d6
3
simvastatin_substrate_of_cyp3a4
3
telithromycin_inhibits_cyp3a4
3
venlafaxine_does_not_inhibit_cyp1a2
3
venlafaxine_has_metabolite_O-desmethylvenlafaxine
3
venlafaxine_maximum_concentration_continuous_value
3
venlafaxine_substrate_of_cyp2d6
3
alprazolam_bioavailability_continuous_value
2
alprazolam_has_metabolite_4-hydroxyalprazolam
2
alprazolam_has_metabolite_alpha-hydroxyalprazolam
2
alprazolam_maximum_concentration_continuous_value
2
alprazolam_primary_metabolic_clearance_enzyme_cyp3a4
2
alprazolam_substrate_of_cyp3a5
2
amiodarone_inhibits_cyp2c9
2
amiodarone_inhibits_cyp2d6
2
aripiprazole_substrate_of_cyp3a4
2
atazanavir_inhibits_cyp3a4
2
atazanavir_inhibits_cyp3a5
2
atomoxetine_does_not_inhibit_cyp2d6
2
atomoxetine_primary_total_clearance_enzyme_cyp2d6
2
atorvastatin_primary_total_clearance_mechanism_Metabolic_Clearance
2
atorvastatin_substrate_of_cyp3a5
2
beta-hydroxy-lovastatin_substrate_of_cyp3a4
2
beta-hydroxy-simvastatin_substrate_of_cyp3a4
2
bupropion_inhibits_cyp2d6
2
celecoxib_inhibits_cyp2d6
2
cimetidine_increases_auc_amitriptyline
2
cimetidine_increases_auc_venlafaxine
2
cinacalcet_does_not_inhibit_cyp3a4
2
cinacalcet_substrate_of_cyp3a4
2
ciprofloxacin_inhibits_cyp1a2
2
citalopram_does_not_inhibit_cyp2c9
2
clarithromycin_has_metabolite_14-hydroxyclarithromycin
2
clarithromycin_increases_auc_atorvastatin
2
clarithromycin_increases_auc_midazolam
2
clarithromycin_inhibits_cyp3a5
2
clarithromycin_substrate_of_cyp3a4
2
clozapine_substrate_of_cyp1a2
2
clozapine_substrate_of_cyp2d6
2
clozapine_substrate_of_cyp3a4
2
cyp1a2_controls_formation_of_N-dealkylperphenazine
2
cyp2b6_controls_formation_of_hydroxybupropion
2
cyp2d6_controls_formation_of_N-dealkylperphenazine
2
cyp3a4_controls_formation_of_14-hydroxyclarithromycin
2
cyp3a4_controls_formation_of_N-dealkylperphenazine
2
cyp3a4_controls_formation_of_N-desmethylvenlafaxine
2
dehydro-aripiprazole_substrate_of_cyp3a4
2
desvenlafaxine_increases_auc_desipramine
2
diltiazem_maximum_concentration_continuous_value
2
duloxetine_substrate_of_cyp2d6
2
erythromycin_inhibits_cyp3a4
2
escitalopram_does_not_inhibit_cyp2c19
2
escitalopram_does_not_inhibit_cyp2c9
2
escitalopram_does_not_inhibit_cyp2d6
2
escitalopram_substrate_of_cyp2c19
2
eszopiclone_substrate_of_cyp3a4
2
fluconazole_inhibits_cyp2c9
2
fluoxetine_increases_auc_desipramine
2
fluoxetine_substrate_of_cyp2d6
2
fluphenazine_maximum_concentration_continuous_value
2
fluvoxamine_increases_auc_duloxetine
2
fluvoxamine_increases_auc_lansoprazole
2
fluvoxamine_inhibition_constant_cyp1a2
2
fluvoxamine_inhibits_cyp2c19
2
fluvoxamine_substrate_of_cyp2d6
2
hydroxybupropion_maximum_concentration_continuous_value
2
iloperidone_substrate_of_cyp2d6
2
itraconazole_increases_auc_triazolam
2
ketoconazole_increases_auc_alprazolam
2
ketoconazole_increases_auc_triazolam
2
ketoconazole_primary_total_clearance_mechanism_Metabolic_Clearance
2
lovastatin_substrate_of_cyp3a4
2
mirtazapine_substrate_of_cyp1a2
2
mirtazapine_substrate_of_cyp2d6
2
mirtazapine_substrate_of_cyp3a4
2
montelukast_does_not_inhibit_cyp1a2
2
montelukast_does_not_inhibit_cyp2c9
2
nefazodone_increases_auc_triazolam
2
nefazodone_is_not_substrate_of_cyp2d6
2
paliperidone_does_not_inhibit_cyp1a2
2
paliperidone_does_not_inhibit_cyp2a6
2
paliperidone_does_not_inhibit_cyp2c9
2
paroxetine_in_viVo_selective_inhibitor_of_enzyme_cyp2d6
2
paroxetine_increases_auc_duloxetine
2
perphenazine_substrate_of_cyp1a2
2
perphenazine_substrate_of_cyp3a4
2
rabeprazole_substrate_of_cyp3a4
2
reduced-haloperidol_substrate_of_cyp3a4
2
risperidone_bioavailability_continuous_value
2
risperidone_has_metabolite_9-hydroxyrisperidone
2
risperidone_inhibition_constant_cyp2d6
2
risperidone_substrate_of_cyp2d6
2
ritonavir_inhibits_cyp2d6
2
rosuvastatin_bioavailability_continuous_value
2
terbinafine_inhibits_cyp2d6
2
thioridazine_has_metabolite_mesoridazine
2
thioridazine_substrate_of_cyp2d6
2
topiramate_does_not_inhibit_cyp1a2
2
topiramate_does_not_inhibit_cyp2a6
2
topiramate_does_not_inhibit_cyp2c9
2
topiramate_does_not_inhibit_cyp2e1
2
topiramate_does_not_inhibit_cyp3a4
2
trazodone_bioavailability_continuous_value
2
venlafaxine_does_not_inhibit_cyp2c9
2
venlafaxine_does_not_inhibit_cyp3a4
2
venlafaxine_has_metabolite_N-desmethylvenlafaxine
2
voriconazole_maximum_concentration_continuous_value
2
zafirlukast_inhibits_cyp2c9
2
ziprasidone_does_not_inhibit_cyp1a2
2
ziprasidone_does_not_inhibit_cyp2c19
2
ziprasidone_does_not_inhibit_cyp2c9
2
ziprasidone_does_not_inhibit_cyp2d6
2
ziprasidone_has_metabolite_ziprasidone-sulphoxide
2
ziprasidone_is_not_substrate_of_cyp1a2
2
zolpidem_substrate_of_cyp3a4
2
1-methylxanthine_has_metabolite_1-methyluric-acid
1
7-ethoxyresorufin_in_vitro_probe_substrate_of_enzyme_cyp1a2
1
7-hydroxyperphenazine_maximum_concentration_continuous_value
1
9-hydroxyrisperidone_inhibition_constant_cyp2d6
1
9-hydroxyrisperidone_primary_total_clearance_mechanism_Renal_Excretion
1
N-demethyldesacetyl-diltiazem_primary_total_clearance_enzyme_cyp2d6
1
N-demethyldesacetyl-diltiazem_substrate_of_cyp2d6
1
N-desalkylquetiapine_does_not_inhibit_cyp1a2
1
N-desalkylquetiapine_does_not_inhibit_cyp2c19
1
N-desalkylquetiapine_does_not_inhibit_cyp2c9
1
N-desalkylquetiapine_does_not_inhibit_cyp2d6
1
N-desalkylquetiapine_does_not_inhibit_cyp3a4
1
N-desalkylquetiapine_substrate_of_cyp3a4
1
R-citalopram_does_not_inhibit_cyp1a2
1
R-citalopram_does_not_inhibit_cyp2c19
1
R-citalopram_does_not_inhibit_cyp2c9
1
R-citalopram_does_not_inhibit_cyp2d6
1
R-citalopram_substrate_of_cyp2c19
1
R-citalopram_substrate_of_cyp2d6
1
R-citalopram_substrate_of_cyp3a4
1
R-demethylcitalopram_does_not_inhibit_cyp1a2
1
R-demethylcitalopram_does_not_inhibit_cyp2c19
1
R-demethylcitalopram_does_not_inhibit_cyp2c9
1
R-demethylcitalopram_maximum_concentration_continuous_value
1
R-demethylcitalopram_substrate_of_cyp2d6
1
R-didemethylcitalopram_does_not_inhibit_cyp1a2
1
R-didemethylcitalopram_does_not_inhibit_cyp2d6
1
R-didemethylcitalopram_maximum_concentration_continuous_value
1
S-demethylcitalopram_does_not_inhibit_cyp1a2
1
S-demethylcitalopram_does_not_inhibit_cyp2c19
1
S-demethylcitalopram_does_not_inhibit_cyp2c9
1
S-demethylcitalopram_maximum_concentration_continuous_value
1
S-demethylcitalopram_substrate_of_cyp2d6
1
S-didemethylcitalopram_does_not_inhibit_cyp1a2
1
S-didemethylcitalopram_does_not_inhibit_cyp2d6
1
S-didemethylcitalopram_maximum_concentration_continuous_value
1
S-mephenytoin_in_vitro_probe_substrate_of_enzyme_cyp2c19
1
S-warfarin_in_vitro_probe_substrate_of_enzyme_cyp2c9
1
S-warfarin_primary_total_clearance_enzyme_cyp2c9
1
alpha-naphthoflavone_in_vitro_selective_inhibitor_of_enzyme_cyp1a2
1
alprazolam_is_not_substrate_of_cyp1a2
1
amiodarone_inhibits_cyp1a2
1
amiodarone_inhibits_cyp3a4
1
aripiprazole_bioavailability_continuous_value
1
aripiprazole_does_not_inhibit_cyp1a2
1
aripiprazole_does_not_inhibit_cyp2c19
1
aripiprazole_does_not_inhibit_cyp2c9
1
aripiprazole_does_not_inhibit_cyp2d6
1
aripiprazole_does_not_inhibit_cyp3a4
1
aripiprazole_has_metabolite_dehydro-aripiprazole
1
aripiprazole_increases_auc_escitalopram
1
aripiprazole_increases_auc_venlafaxine
1
aripiprazole_is_not_substrate_of_cyp1a1
1
aripiprazole_is_not_substrate_of_cyp1a2
1
aripiprazole_is_not_substrate_of_cyp2a6
1
aripiprazole_is_not_substrate_of_cyp2b6
1
aripiprazole_is_not_substrate_of_cyp2c19
1
aripiprazole_is_not_substrate_of_cyp2c8
1
aripiprazole_is_not_substrate_of_cyp2c9
1
aripiprazole_is_not_substrate_of_cyp2e1
1
aripiprazole_primary_total_clearance_mechanism_Metabolic_Clearance
1
aripiprazole_substrate_of_cyp2d6
1
asenapine_is_not_substrate_of_cyp2d6
1
asenapine_maximum_concentration_continuous_value
1
asenapine_primary_total_clearance_mechanism_Metabolic_Clearance
1
atazanavir_does_not_inhibit_cyp1a2
1
atazanavir_does_not_inhibit_cyp2a6
1
atazanavir_does_not_inhibit_cyp2b6
1
atazanavir_does_not_inhibit_cyp2c19
1
atazanavir_does_not_inhibit_cyp2c9
1
atazanavir_does_not_inhibit_cyp2d6
1
atazanavir_does_not_inhibit_cyp2e1
1
atomoxetine_bioavailability_continuous_value
1
atomoxetine_does_not_inhibit_cyp1a2
1
atomoxetine_does_not_inhibit_cyp2c9
1
atomoxetine_has_metabolite_4-hydroxyatomoxetine
1
atomoxetine_has_metabolite_N-desmethylatomoxetine
1
atomoxetine_primary_total_clearance_mechanism_Metabolic_Clearance
1
atorvastatin_bioavailability_continuous_value
1
atorvastatin_inhibition_constant_cyp2c8
1
atorvastatin_inhibits_cyp3a4
1
atorvastatin_is_not_substrate_of_cyp1a1
1
atorvastatin_is_not_substrate_of_cyp2b6
1
atorvastatin_is_not_substrate_of_cyp2c19
1
atorvastatin_is_not_substrate_of_cyp2c9
1
atorvastatin_is_not_substrate_of_cyp2d6
1
atorvastatin_is_not_substrate_of_cyp2e1
1
atorvastatin_primary_total_clearance_enzyme_cyp3a4
1
beta-hydroxy-lovastatin_has_metabolite_6'-exomethylene-lovastatin
1
beta-hydroxy-lovastatin_has_metabolite_6'beta-hydroxy-lovastatin
1
beta-hydroxy-lovastatin_inhibition_constant_cyp2c8
1
beta-hydroxy-lovastatin_maximum_concentration_continuous_value
1
beta-hydroxy-lovastatin_primary_total_clearance_enzyme_cyp3a4
1
beta-hydroxy-simvastatin_does_not_inhibit_cyp3a4
1
beta-hydroxy-simvastatin_has_metabolite_6'-exomethylene-simvastatin
1
beta-hydroxy-simvastatin_has_metabolite_6'-hydroxy-simvastatin
1
beta-hydroxy-simvastatin_has_metabolite_6'-hydroxymethyl-simvastatin
1
beta-hydroxy-simvastatin_inhibition_constant_cyp2c8
1
beta-hydroxy-simvastatin_primary_total_clearance_enzyme_cyp3a4
1
bufuralol_in_vitro_probe_substrate_of_enzyme_cyp2d6
1
bupropion_has_metabolite_erythrohydrobupropion
1
bupropion_has_metabolite_hydroxybupropion
1
bupropion_has_metabolite_threohydrobupropion
1
bupropion_increases_auc_desipramine
1
bupropion_primary_total_clearance_mechanism_Metabolic_Clearance
1
bupropion_substrate_of_cyp2b6
1
caffeine_primary_total_clearance_enzyme_cyp1a2
1
celecoxib_does_not_inhibit_cyp2c19
1
celecoxib_does_not_inhibit_cyp2c9
1
celecoxib_does_not_inhibit_cyp3a4
1
celecoxib_maximum_concentration_continuous_value
1
celecoxib_primary_total_clearance_mechanism_Metabolic_Clearance
1
celecoxib_substrate_of_cyp2c9
1
chlorpromazine_bioavailability_continuous_value
1
chlorpromazine_does_not_inhibit_cyp2c19
1
chlorzoxazone_in_vitro_probe_substrate_of_enzyme_cyp2e1
1
cimetidine_increases_auc_citalopram
1
cimetidine_increases_auc_doxepin
1
cimetidine_increases_auc_erythrohydrobupropion
1
cimetidine_increases_auc_escitalopram
1
cimetidine_increases_auc_mirtazapine
1
cimetidine_increases_auc_paroxetine
1
cimetidine_increases_auc_quetiapine
1
cimetidine_increases_auc_sertraline
1
cimetidine_increases_auc_theophylline
1
cimetidine_increases_auc_threohydrobupropion
1
cimetidine_increases_auc_ziprasidone
1
cimetidine_inhibits_cyp1a2
1
cimetidine_inhibits_cyp3a4
1
cimetidine_inhibits_cyp3a5
1
cinacalcet_does_not_inhibit_cyp1a2
1
cinacalcet_does_not_inhibit_cyp2c19
1
cinacalcet_does_not_inhibit_cyp2c9
1
cinacalcet_does_not_inhibit_cyp3a5
1
cinacalcet_has_metabolite_hydrocinnamic-acid
1
cinacalcet_has_metabolite_hydroxy-hydrocinnamic-acid
1
cinacalcet_primary_total_clearance_mechanism_Metabolic_Clearance
1
cinacalcet_substrate_of_cyp1a2
1
cinacalcet_substrate_of_cyp2d6
1
citalopram_bioavailability_continuous_value
1
citalopram_does_not_inhibit_cyp2e1
1
citalopram_has_metabolite_demethylcitalopram
1
citalopram_has_metabolite_didemethylcitalopram
1
citalopram_increases_auc_desipramine
1
citalopram_is_not_substrate_of_cyp3a4
1
citalopram_primary_total_clearance_mechanism_Metabolic_Clearance
1
citalopram_substrate_of_cyp2c19
1
citalopram_substrate_of_cyp3a4
1
clarithromycin_bioavailability_continuous_value
1
clarithromycin_fraction_absorbed_continuous_value
1
clarithromycin_in_viVo_selective_inhibitor_of_enzyme_cyp3a4
1
clarithromycin_increases_auc_lansoprazole
1
clarithromycin_increases_auc_pravastatin
1
clarithromycin_increases_auc_trazodone
1
clarithromycin_increases_auc_triazolam
1
clarithromycin_is_not_substrate_of_cyp1a2
1
clarithromycin_is_not_substrate_of_cyp2c9
1
clarithromycin_is_not_substrate_of_cyp2d6
1
clopidogrel_increases_auc_bupropion
1
clopidogrel_inhibition_constant_cyp2b6
1
clozapine-N-oxide_is_not_substrate_of_cyp2d6
1
clozapine_does_not_inhibit_cyp2c19
1
clozapine_has_metabolite_7-hydroxyclozapine
1
clozapine_has_metabolite_clozapine-N-oxide
1
clozapine_has_metabolite_desmethylclozapine
1
clozapine_inhibition_constant_cyp2c19
1
clozapine_inhibition_constant_cyp2c9
1
clozapine_inhibition_constant_cyp2d6
1
clozapine_inhibition_constant_cyp3a4
1
clozapine_primary_total_clearance_mechanism_Metabolic_Clearance
1
coumarin_in_vitro_probe_substrate_of_enzyme_cyp2a6
1
cyp1a2_controls_formation_of_3-methylxanthine
1
cyp2c19_controls_formation_of_N-dealkylperphenazine
1
cyp2c19_controls_formation_of_N-desmethylatomoxetine
1
cyp2c19_controls_formation_of_N-desmethylsertraline
1
cyp2c8_controls_formation_of_6alpha-hydroxy-paclitaxel
1
cyp2c8_controls_formation_of_N-dealkylperphenazine
1
cyp2c9_controls_formation_of_N-dealkylperphenazine
1
cyp2c9_controls_formation_of_N-desmethylrosuvastatin
1
cyp2d6_controls_formation_of_4-hydroxyatomoxetine
1
cyp2d6_controls_formation_of_4-hydroxydebrisoquine
1
cyp2d6_controls_formation_of_9-hydroxyrisperidone
1
cyp2e1_controls_formation_of_1,3-dimethyluric-acid
1
cyp3a4_controls_formation_of_1'-hydroxymidazolam
1
cyp3a4_controls_formation_of_1,3-dimethyluric-acid
1
cyp3a4_controls_formation_of_4-hydroxyalprazolam
1
cyp3a4_controls_formation_of_4-hydroxymidazolam
1
cyp3a4_controls_formation_of_6'beta-hydroxy-lovastatin
1
cyp3a4_controls_formation_of_N-desmethyltamoxifen
1
cyp3a4_controls_formation_of_alpha-hydroxyalprazolam
1
cyp3a4_controls_formation_of_desmethylcitalopram
1
cyp3a4_controls_formation_of_ortho-hydroxy-atorvastatin
1
cyp3a4_controls_formation_of_para-hydroxy-atorvastatin
1
cyp3a4_controls_formation_of_ziprasidone-sulphoxide
1
cyp3a5_controls_formation_of_1'-hydroxymidazolam
1
cyp3a5_controls_formation_of_4-hydroxyalprazolam
1
cyp3a5_controls_formation_of_4-hydroxymidazolam
1
cyp3a5_controls_formation_of_alpha-hydroxyalprazolam
1
cyp3a5_controls_formation_of_ortho-hydroxy-atorvastatin
1
cyp3a5_controls_formation_of_para-hydroxy-atorvastatin
1
debrisoquine_in_vitro_probe_substrate_of_enzyme_cyp2d6
1
dehydro-aripiprazole_does_not_inhibit_cyp1a2
1
demethylcitalopram_does_not_inhibit_cyp3a4
1
demethylcitalopram_is_not_substrate_of_cyp2c19
1
demethylcitalopram_is_not_substrate_of_cyp3a4
1
desacetyldiltiazem_primary_total_clearance_enzyme_cyp2d6
1
desacetyldiltiazem_substrate_of_cyp2d6
1
desglymidodrine_primary_total_clearance_mechanism_Renal_Excretion
1
desipramine_primary_total_clearance_enzyme_cyp2d6
1
desvenlafaxine_is_not_substrate_of_cyp2d6
1
dextromethorphan_in_viVo_probe_substrate_of_enzyme_cyp2d6
1
dextromethorphan_in_vitro_probe_substrate_of_enzyme_cyp2d6
1
dextromethorphan_primary_total_clearance_enzyme_cyp2d6
1
diltiazem_has_metabolite_N-demethyldesacetyl-diltiazem
1
diltiazem_has_metabolite_N-demethyldiltiazem
1
diltiazem_has_metabolite_desacetyldiltiazem
1
diltiazem_increases_auc_beta-hydroxy-lovastatin
1
diltiazem_increases_auc_imipramine
1
diltiazem_increases_auc_midazolam
1
diltiazem_increases_auc_simvastatin
1
diltiazem_increases_auc_triazolam
1
diltiazem_inhibits_cyp3a4
1
diltiazem_permanently_deactivates_catalytic_function_cyp3a4
1
diltiazem_primary_total_clearance_mechanism_Metabolic_Clearance
1
diltiazem_substrate_of_cyp3a4
1
diltiazem_substrate_of_cyp3a5
1
diphenhydramine_increases_auc_venlafaxine
1
duloxetine_does_not_inhibit_cyp2c19
1
duloxetine_does_not_inhibit_cyp2c9
1
duloxetine_does_not_inhibit_cyp3a4
1
duloxetine_does_not_inhibit_cyp3a5
1
duloxetine_increases_auc_theophylline
1
duloxetine_primary_total_clearance_mechanism_Metabolic_Clearance
1
duloxetine_substrate_of_cyp1a2
1
erythrohydrobupropion_maximum_concentration_continuous_value
1
erythromycin_in_vitro_probe_substrate_of_enzyme_cyp3a4
1
erythromycin_increases_auc_alprazolam
1
erythromycin_increases_auc_atorvastatin
1
erythromycin_increases_auc_beta-hydroxy-simvastatin
1
erythromycin_increases_auc_midazolam
1
erythromycin_increases_auc_quetiapine
1
erythromycin_increases_auc_simvastatin
1
erythromycin_increases_auc_triazolam
1
escitalopram_bioavailability_continuous_value
1
escitalopram_does_not_inhibit_cyp1a2
1
escitalopram_does_not_inhibit_cyp2e1
1
escitalopram_has_metabolite_S-demethylcitalopram
1
escitalopram_has_metabolite_S-didemethylcitalopram
1
escitalopram_inhibits_cyp2d6
1
escitalopram_maximum_concentration_continuous_value
1
escitalopram_primary_total_clearance_mechanism_Metabolic_Clearance
1
escitalopram_substrate_of_cyp2d6
1
escitalopram_substrate_of_cyp3a4
1
eszopiclone_does_not_inhibit_CYP1A2
1
eszopiclone_does_not_inhibit_CYP2A6
1
eszopiclone_does_not_inhibit_CYP2C19
1
eszopiclone_does_not_inhibit_CYP2C9
1
eszopiclone_does_not_inhibit_CYP2D6
1
eszopiclone_does_not_inhibit_CYP2E1
1
eszopiclone_does_not_inhibit_CYP3A4
1
eszopiclone_has_metabolite_S-N-desmethylzopiclone
1
eszopiclone_has_metabolite_S-zopiclone-N-oxide
1
fluconazole_bioavailability_continuous_value
1
fluconazole_increases_auc_fluvastatin
1
fluconazole_increases_auc_triazolam
1
fluconazole_inhibition_constant_cyp3a4
1
fluconazole_inhibits_cyp3a5
1
fluconazole_maximum_concentration_continuous_value
1
fluconazole_primary_total_clearance_mechanism_Renal_Excretion
1
fluoxetine_has_metabolite_norfluoxetine
1
fluoxetine_in_viVo_selective_inhibitor_of_enzyme_cyp2d6
1
fluoxetine_increases_auc_alprazolam
1
fluoxetine_increases_auc_imipramine
1
fluoxetine_increases_auc_olanzapine
1
fluoxetine_increases_auc_propafenone
1
fluoxetine_inhibition_constant_cyp3a4
1
fluoxetine_maximum_concentration_continuous_value
1
fluoxetine_primary_total_clearance_mechanism_Metabolic_Clearance
1
fluphenazine_bioavailability_continuous_value
1
fluphenazine_does_not_inhibit_cyp2c19
1
fluphenazine_inhibition_constant_cyp1a2
1
fluphenazine_inhibition_constant_cyp2d6
1
fluvastatin_bioavailability_continuous_value
1
fluvastatin_inhibition_constant_cyp2c8
1
fluvastatin_primary_total_clearance_enzyme_cyp2c9
1
fluvastatin_primary_total_clearance_mechanism_Metabolic_Clearance
1
fluvastatin_substrate_of_cyp2c8
1
fluvastatin_substrate_of_cyp2c9
1
fluvastatin_substrate_of_cyp3a4
1
fluvoxamine_bioavailability_continuous_value
1
fluvoxamine_increases_auc_clozapine
1
fluvoxamine_increases_auc_mexiletine
1
fluvoxamine_increases_auc_omeprazole
1
fluvoxamine_increases_auc_quinidine
1
fluvoxamine_increases_auc_theophylline
1
fluvoxamine_increases_auc_thioridazine
1
fluvoxamine_increases_auc_tolbutamide
1
fluvoxamine_inhibits_cyp2c9
1
fluvoxamine_primary_total_clearance_mechanism_Metabolic_Clearance
1
furafylline_in_vitro_selective_inhibitor_of_enzyme_cyp1a2
1
gemfibrozil_inhibits_cyp2c8
1
haloperidol_does_not_inhibit_cyp2c19
1
haloperidol_has_metabolite_4-(4-chlorophenyl)-4-hydroxypiperidine
1
haloperidol_has_metabolite_reduced-haloperidol
1
haloperidol_inhibition_constant_cyp2d6
1
haloperidol_substrate_of_cyp3a4
1
hydroxybupropion_primary_total_clearance_mechanism_Renal_Excretion
1
iloperidone_inhibits_cyp2d6
1
iloperidone_is_not_substrate_of_cyp1a1
1
iloperidone_is_not_substrate_of_cyp1a2
1
iloperidone_is_not_substrate_of_cyp2a6
1
iloperidone_is_not_substrate_of_cyp2b6
1
iloperidone_is_not_substrate_of_cyp2c19
1
iloperidone_is_not_substrate_of_cyp2c8
1
iloperidone_is_not_substrate_of_cyp2c9
1
iloperidone_is_not_substrate_of_cyp2e1
1
iloperidone_substrate_of_cyp3a4
1
indinavir_does_not_inhibit_cyp1a2
1
indinavir_does_not_inhibit_cyp2b6
1
indinavir_does_not_inhibit_cyp2c9
1
indinavir_does_not_inhibit_cyp2e1
1
indinavir_inhibits_cyp3a5
1
indomethacin_bioavailability_continuous_value
1
indomethacin_primary_total_clearance_mechanism_Metabolic_Clearance
1
itraconazole_in_viVo_selective_inhibitor_of_enzyme_cyp3a4
1
itraconazole_in_vitro_selective_inhibitor_of_enzyme_cyp3a4
1
itraconazole_in_vitro_selective_inhibitor_of_enzyme_cyp3a5
1
itraconazole_increases_auc_3alpha-hydroxypravastatin
1
itraconazole_increases_auc_alprazolam
1
itraconazole_increases_auc_atorvastatin
1
itraconazole_increases_auc_beta-hydroxy-lovastatin
1
itraconazole_increases_auc_lovastatin
1
itraconazole_increases_auc_midazolam
1
itraconazole_increases_auc_pravastatin
1
itraconazole_increases_auc_rosuvastatin
1
itraconazole_increases_auc_zolpidem
1
itraconazole_inhibition_constant_cyp3a4
1
itraconazole_inhibits_cyp3a4
1
ketoconazole_in_viVo_selective_inhibitor_of_enzyme_cyp3a4
1
ketoconazole_in_vitro_selective_inhibitor_of_enzyme_cyp3a4
1
ketoconazole_increases_auc_O-desmethylvenlafaxine
1
ketoconazole_increases_auc_amitriptyline
1
ketoconazole_increases_auc_desvenlafaxine
1
ketoconazole_increases_auc_imipramine
1
ketoconazole_increases_auc_midazolam
1
ketoconazole_increases_auc_simvastatin
1
ketoconazole_increases_auc_venlafaxine
1
ketoconazole_increases_auc_zolpidem
1
ketoconazole_inhibition_constant_cyp3a4
1
ketoconazole_maximum_concentration_continuous_value
1
lansoprazole_bioavailability_continuous_value
1
lansoprazole_does_not_inhibit_cyp2d6
1
lansoprazole_does_not_inhibit_cyp3a4
1
lansoprazole_increases_auc_lansoprazole
1
lansoprazole_maximum_concentration_continuous_value
1
lansoprazole_primary_total_clearance_enzyme_cyp2c19
1
lansoprazole_primary_total_clearance_mechanism_Metabolic_Clearance
1
lansoprazole_substrate_of_cyp2c19
1
lansoprazole_substrate_of_cyp3a4
1
lansoprazole_substrate_of_cyp3a5
1
leflunomide_has_metabolite_teriflunomide
1
lovastatin_bioavailability_continuous_value
1
lovastatin_first_pass_effect_continuous_value
1
lovastatin_has_metabolite_beta-hydroxy-lovastatin
1
lovastatin_inhibition_constant_cyp2c8
1
lovastatin_maximum_concentration_continuous_value
1
lovastatin_primary_total_clearance_enzyme_cyp3a4
1
lovastatin_primary_total_clearance_mechanism_Metabolic_Clearance
1
mephenytoin_in_viVo_probe_substrate_of_enzyme_cyp2c19
1
midazolam_has_metabolite_1'-hydroxymidazolam
1
midazolam_has_metabolite_4-hydroxymidazolam
1
midazolam_in_vitro_probe_substrate_of_enzyme_cyp3a4
1
midazolam_primary_total_clearance_enzyme_cyp3a4
1
midazolam_substrate_of_cyp3a5
1
midodrine_bioavailability_continuous_value
1
midodrine_has_metabolite_desglymidodrine
1
mirtazapine_bioavailability_continuous_value
1
mirtazapine_does_not_inhibit_cyp1a2
1
mirtazapine_does_not_inhibit_cyp2c19
1
mirtazapine_does_not_inhibit_cyp2c9
1
mirtazapine_does_not_inhibit_cyp2d6
1
mirtazapine_does_not_inhibit_cyp2e1
1
mirtazapine_fraction_absorbed_continuous_value
1
mirtazapine_is_not_substrate_of_cyp2a6
1
mirtazapine_is_not_substrate_of_cyp2b6
1
mirtazapine_is_not_substrate_of_cyp2c19
1
mirtazapine_is_not_substrate_of_cyp2e1
1
mirtazapine_substrate_of_cyp3a5
1
modafinil-sulfone_inhibits_cyp2c19
1
modafinil_has_metabolite_modafinil-sulfone
1
modafinil_inhibits_cyp2c19
1
modafinil_primary_total_clearance_mechanism_Metabolic_Clearance
1
modafinil_substrate_of_cyp3a4
1
molindone_primary_total_clearance_mechanism_Metabolic_Clearance
1
montelukast_does_not_inhibit_cyp2a6
1
montelukast_does_not_inhibit_cyp2c19
1
montelukast_does_not_inhibit_cyp2c8
1
montelukast_does_not_inhibit_cyp2d6
1
montelukast_does_not_inhibit_cyp3a4
1
montelukast_inhibition_constant_cyp2c8
1
nefazodone_does_not_inhibit_cyp1a2
1
nefazodone_in_viVo_selective_inhibitor_of_enzyme_cyp3a4
1
nefazodone_increases_auc_midazolam
1
nefazodone_inhibits_cyp3a5
1
nefazodone_is_not_substrate_of_cyp1a2
1
nefazodone_is_not_substrate_of_cyp2c19
1
nefazodone_is_not_substrate_of_cyp2c8
1
nefazodone_is_not_substrate_of_cyp2c9
1
nefazodone_substrate_of_cyp3a4
1
nicardipine_bioavailability_continuous_value
1
norfloxacin_inhibits_cyp1a2
1
norfluoxetine_inhibition_constant_cyp3a4
1
olanzapine_has_metabolite_10-N-glucuronide
1
olanzapine_inhibition_constant_cyp2c19
1
olanzapine_inhibition_constant_cyp2c9
1
olanzapine_inhibition_constant_cyp3a4
1
olanzapine_maximum_concentration_continuous_value
1
olanzapine_primary_total_clearance_mechanism_Metabolic_Clearance
1
olanzapine_substrate_of_cyp2d6
1
omeprazole_does_not_inhibit_cyp2d6
1
omeprazole_in_vitro_probe_substrate_of_enzyme_cyp2c19
1
omeprazole_in_vitro_selective_inhibitor_of_enzyme_cyp2c19
1
omeprazole_increases_auc_escitalopram
1
omeprazole_inhibits_cyp2c19
1
omeprazole_primary_total_clearance_enzyme_cyp2c19
1
p-nitrophenol_in_vitro_probe_substrate_of_enzyme_cyp2e1
1
paclitaxel_has_metabolite_6alpha-hydroxy-paclitaxel
1
paclitaxel_in_vitro_probe_substrate_of_enzyme_cyp2c8
1
paliperidone_bioavailability_continuous_value
1
paliperidone_does_not_inhibit_cyp2c19
1
paliperidone_does_not_inhibit_cyp2c8
1
paliperidone_does_not_inhibit_cyp2d6
1
paliperidone_does_not_inhibit_cyp2e1
1
paliperidone_does_not_inhibit_cyp3a4
1
paliperidone_does_not_inhibit_cyp3a5
1
paliperidone_inhibition_constant_cyp2d6
1
paliperidone_primary_total_clearance_mechanism_Renal_Excretion
1
pantoprazole_bioavailability_continuous_value
1
pantoprazole_does_not_inhibit_cyp2d6
1
pantoprazole_maximum_concentration_continuous_value
1
pantoprazole_primary_total_clearance_enzyme_cyp2c19
1
pantoprazole_primary_total_clearance_mechanism_Metabolic_Clearance
1
pantoprazole_substrate_of_cyp2c19
1
pantoprazole_substrate_of_cyp3a4
1
paroxetine_increases_auc_imipramine
1
paroxetine_increases_auc_mirtazapine
1
paroxetine_increases_auc_nortriptyline
1
paroxetine_increases_auc_paliperidone
1
paroxetine_increases_auc_risperidone
1
paroxetine_permanently_deactivates_catalytic_function_cyp2d6
1
paroxetine_primary_total_clearance_mechanism_Metabolic_Clearance
1
paroxetine_substrate_of_cyp2d6
1
perphenazine_does_not_inhibit_cyp2c19
1
perphenazine_has_metabolite_7-hydroxyperphenazine
1
perphenazine_inhibition_constant_cyp1a2
1
perphenazine_inhibition_constant_cyp2d6
1
perphenazine_maximum_concentration_continuous_value
1
perphenazine_primary_total_clearance_mechanism_Metabolic_Clearance
1
perphenazine_substrate_of_cyp2c19
1
phenacetin_in_vitro_probe_substrate_of_enzyme_cyp1a2
1
pioglitazone_inhibition_constant_cyp2c8
1
prasugrel_increases_auc_bupropion
1
pravastatin_does_not_inhibit_cyp2c8
1
pravastatin_has_metabolite_3alpha-hydroxypravastatin
1
pravastatin_primary_total_clearance_mechanism_Renal_Excretion
1
propafenone_inhibits_cyp1a2
1
propoxyphene_has_metabolite_norpropoxyphene
1
quetiapine_does_not_inhibit_cyp1a2
1
quetiapine_does_not_inhibit_cyp2c19
1
quetiapine_does_not_inhibit_cyp2c9
1
quetiapine_does_not_inhibit_cyp2d6
1
quetiapine_does_not_inhibit_cyp3a4
1
quetiapine_has_metabolite_7-hydroxy-N-desalkyl-quetiapine
1
quetiapine_has_metabolite_7-hydroxy-quetiapine
1
quetiapine_has_metabolite_N-desalkylquetiapine
1
quetiapine_has_metabolite_quetiapine-sulfoxide
1
quetiapine_is_not_substrate_of_cyp1a2
1
quetiapine_is_not_substrate_of_cyp2c19
1
quetiapine_is_not_substrate_of_cyp2c9
1
quetiapine_is_not_substrate_of_cyp2e1
1
quetiapine_primary_total_clearance_mechanism_Metabolic_Clearance
1
quinidine_in_viVo_selective_inhibitor_of_enzyme_cyp2d6
1
quinidine_in_vitro_selective_inhibitor_of_enzyme_cyp2d6
1
quinidine_increases_auc_venlafaxine
1
quinidine_inhibits_cyp2d6
1
rabeprazole_bioavailability_continuous_value
1
rabeprazole_primary_total_clearance_mechanism_Metabolic_Clearance
1
rabeprazole_substrate_of_cyp2c19
1
rabeprazole_substrate_of_cyp3a5
1
ranolazine_inhibits_cyp2d6
1
ranolazine_inhibits_cyp3a4
1
ranolazine_inhibits_cyp3a5
1
ranolazine_maximum_concentration_continuous_value
1
ranolazine_primary_total_clearance_enzyme_cyp3a4
1
ranolazine_primary_total_clearance_mechanism_Metabolic_Clearance
1
ranolazine_substrate_of_cyp2d6
1
reduced-haloperidol_has_metabolite_4-(4-chlorophenyl)-4-hydroxypiperidine
1
risperidone_does_not_inhibit_cyp2c19
1
risperidone_maximum_concentration_continuous_value
1
risperidone_primary_metabolic_clearance_enzyme_cyp2d6
1
risperidone_primary_total_clearance_mechanism_Metabolic_Clearance
1
risperidone_substrate_of_cyp3a4
1
ritonavir_increases_auc_trazodone
1
ritonavir_inhibits_cyp3a5
1
rosiglitazone_does_not_inhibit_cyp1a1
1
rosiglitazone_does_not_inhibit_cyp1a2
1
rosiglitazone_does_not_inhibit_cyp2a6
1
rosiglitazone_does_not_inhibit_cyp2b6
1
rosiglitazone_does_not_inhibit_cyp2c19
1
rosiglitazone_does_not_inhibit_cyp2c8
1
rosiglitazone_does_not_inhibit_cyp2c9
1
rosiglitazone_does_not_inhibit_cyp2d6
1
rosiglitazone_does_not_inhibit_cyp2e1
1
rosiglitazone_does_not_inhibit_cyp3a4
1
rosiglitazone_does_not_inhibit_cyp3a5
1
rosiglitazone_inhibition_constant_cyp2c8
1
rosiglitazone_primary_total_clearance_enzyme_cyp2c8
1
rosuvastatin_does_not_inhibit_cyp2c8
1
rosuvastatin_fraction_absorbed_continuous_value
1
rosuvastatin_has_metabolite_N-desmethylrosuvastatin
1
rosuvastatin_is_not_substrate_of_cyp3a4
1
rosuvastatin_maximum_concentration_continuous_value
1
rosuvastatin_primary_metabolic_clearance_enzyme_cyp2c9
1
rosuvastatin_primary_total_clearance_mechanism_Biliary_Excretion
1
sertraline_has_metabolite_N-desmethylsertraline
1
sertraline_substrate_of_cyp2c19
1
sildenafil_primary_total_clearance_enzyme_cyp3a4
1
simvastatin_does_not_inhibit_cyp3a4
1
simvastatin_has_metabolite_beta-hydroxy-simvastatin
1
simvastatin_inhibition_constant_cyp2c8
1
simvastatin_primary_total_clearance_enzyme_cyp3a4
1
simvastatin_primary_total_clearance_mechanism_Metabolic_Clearance
1
sulfinpyrazone_in_vitro_selective_inhibitor_of_enzyme_cyp2c9
1
sulphaphenazole_in_vitro_selective_inhibitor_of_enzyme_cyp2c9
1
tamoxifen_has_metabolite_4-hydroxytamoxifin
1
tamoxifen_has_metabolite_N-desmethyltamoxifen
1
tamoxifen_primary_total_clearance_mechanism_Metabolic_Clearance
1
tamoxifen_substrate_of_cyp2c9
1
tamoxifen_substrate_of_cyp2d6
1
tamoxifen_substrate_of_cyp3a4
1
tamoxifen_substrate_of_cyp3a5
1
telithromycin_inhibits_cyp3a5
1
terbinafine_increases_auc_paroxetine
1
terbinafine_increases_auc_venlafaxine
1
teriflunomide_inhibits_cyp2c9
1
testosterone_in_vitro_probe_substrate_of_enzyme_cyp3a4
1
theophylline_has_metabolite_1,3-dimethyluric-acid
1
theophylline_has_metabolite_1-methylxanthine
1
theophylline_has_metabolite_3-methylxanthine
1
theophylline_has_metabolite_caffeine
1
theophylline_in_vitro_probe_substrate_of_enzyme_cyp1a2
1
theophylline_primary_total_clearance_enzyme_cyp1a2
1
theophylline_primary_total_clearance_mechanism_Metabolic_Clearance
1
thioridazine_does_not_inhibit_cyp2c19
1
thioridazine_has_metabolite_sulforidazine
1
thioridazine_has_metabolite_thioridazine-5-sulfoxide
1
thioridazine_inhibition_constant_cyp2d6
1
thioridazine_primary_total_clearance_enzyme_cyp2d6
1
thiothixene_does_not_inhibit_cyp2c19
1
thiothixene_inhibition_constant_cyp2d6
1
threohydrobupropion_maximum_concentration_continuous_value
1
threohydrobupropion_primary_total_clearance_mechanism_Renal_Excretion
1
ticlopidine_increases_auc_bupropion
1
ticlopidine_inhibition_constant_cyp2b6
1
ticlopidine_inhibition_constant_cyp2c19
1
tolbutamide_in_vitro_probe_substrate_of_enzyme_cyp2c9
1
tolbutamide_primary_total_clearance_enzyme_cyp2c9
1
topiramate_does_not_inhibit_cyp2b6
1
topiramate_does_not_inhibit_cyp2c19
1
topiramate_does_not_inhibit_cyp2d6
1
topiramate_does_not_inhibit_cyp3a5
1
topiramate_primary_total_clearance_mechanism_Renal_Excretion
1
trazodone_has_metabolite_M-chlorophenylpiperazine
1
trazodone_maximum_concentration_continuous_value
1
trazodone_substrate_of_cyp3a4
1
triazolam_in_vitro_probe_substrate_of_enzyme_cyp3a4
1
triazolam_primary_total_clearance_enzyme_cyp3a4
1
trimethoprim_inhibits_cyp2c8
1
troleandomycin_in_vitro_selective_inhibitor_of_enzyme_cyp3a4
1
valproate_increases_auc_hydroxybupropion
1
valproate_primary_total_clearance_mechanism_Metabolic_Clearance
1
venlafaxine_fraction_absorbed_continuous_value
1
venlafaxine_increases_auc_desipramine
1
venlafaxine_increases_auc_haloperidol
1
venlafaxine_increases_auc_imipramine
1
venlafaxine_increases_auc_risperidone
1
venlafaxine_inhibits_cyp2d6
1
venlafaxine_primary_total_clearance_enzyme_cyp2d6
1
venlafaxine_primary_total_clearance_mechanism_Metabolic_Clearance
1
venlafaxine_substrate_of_cyp3a4
1
verapamil_increases_auc_imipramine
1
verapamil_increases_auc_risperidone
1
verapamil_inhibits_cyp1a2
1
verapamil_inhibits_cyp3a4
1
verapamil_inhibits_cyp3a5
1
voriconazole-N-oxide_inhibits_cyp2c19
1
voriconazole-N-oxide_inhibits_cyp2c9
1
voriconazole-N-oxide_inhibits_cyp3a4
1
voriconazole_bioavailability_continuous_value
1
voriconazole_has_metabolite_voriconazole-N-oxide
1
voriconazole_inhibits_cyp2c19
1
voriconazole_inhibits_cyp2c9
1
voriconazole_inhibits_cyp3a4
1
voriconazole_primary_total_clearance_enzyme_cyp2c19
1
voriconazole_primary_total_clearance_mechanism_Metabolic_Clearance
1
voriconazole_substrate_of_cyp2c19
1
voriconazole_substrate_of_cyp2c9
1
voriconazole_substrate_of_cyp3a4
1
warfarin_primary_total_clearance_enzyme_cyp2c9
1
zafirlukast_inhibits_cyp3a4
1
zafirlukast_maximum_concentration_continuous_value
1
zafirlukast_substrate_of_cyp2c9
1
zaleplon_bioavailability_continuous_value
1
zaleplon_is_not_substrate_of_cyp2d6
1
zaleplon_primary_total_clearance_mechanism_Metabolic_Clearance
1
zaleplon_substrate_of_cyp3a4
1
ziprasidone_does_not_inhibit_cyp3a4
1
ziprasidone_has_metabolite_S-methyl-dihydroziprasidone
1
ziprasidone_has_metabolite_benzisothiazole-sulphone
1
ziprasidone_has_metabolite_benzisothiazole-sulphoxide
1
ziprasidone_inhibition_constant_cyp2d6
1
ziprasidone_is_not_substrate_of_cyp2c19
1
ziprasidone_is_not_substrate_of_cyp2c9
1
ziprasidone_is_not_substrate_of_cyp2d6
1
ziprasidone_primary_total_clearance_mechanism_Metabolic_Clearance
1
ziprasidone_substrate_of_cyp1a2
1
zolpidem_maximum_concentration_continuous_value
1
zolpidem_substrate_of_cyp3a5
1